This medication, taken as a once-weekly injection, functions to regulate blood sugar levels and serves as an integral part of diabetes treatment
Buyer Takeaway: The regulatory outcome is uncertain as of June 2026 but is likely to restrict large-scale compounded GLP-1 availability
However, if youre off treatment for more than 4 weeks, youll typically need to start over at the beginning dose of 0.25 mg and work back up through the titration schedule
As a precaution, please refrigerate once received and opened
for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
Anti-tirzepatide antibodies are immune proteins that the body may produce in response to tirzepatide (Mounjaro, Zepbound), a synthetic peptide drug that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
